Free Trial
Your $100 Credit Expires Tomorrow! Get MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$339.30
+0.6%
$345.10
$267.83
$391.29
$183.12B0.442.82 million shs1.57 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$134.36
+3.0%
$136.27
$104.46
$157.29
$166.82B0.316.24 million shs5.97 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$46.88
-0.8%
$50.82
$22.28
$59.55
$18.60B1.058.07 million shs4.22 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.92
-0.1%
$26.86
$22.88
$28.75
$147.62B0.3537.77 million shs22.30 million shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
0.00%+3.98%-2.67%-9.46%+25.05%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.00%+3.69%+0.54%-11.25%+24.73%
Moderna, Inc. stock logo
MRNA
Moderna
0.00%-4.40%-11.30%-6.00%+81.71%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+2.41%-2.74%-2.76%+12.40%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$339.30
+0.6%
$345.10
$267.83
$391.29
$183.12B0.442.82 million shs1.57 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$134.36
+3.0%
$136.27
$104.46
$157.29
$166.82B0.316.24 million shs5.97 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$46.88
-0.8%
$50.82
$22.28
$59.55
$18.60B1.058.07 million shs4.22 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.92
-0.1%
$26.86
$22.88
$28.75
$147.62B0.3537.77 million shs22.30 million shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
0.00%+3.98%-2.67%-9.46%+25.05%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.00%+3.69%+0.54%-11.25%+24.73%
Moderna, Inc. stock logo
MRNA
Moderna
0.00%-4.40%-11.30%-6.00%+81.71%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+2.41%-2.74%-2.76%+12.40%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.48
Hold$355.194.68% Upside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.86
Moderate Buy$156.9316.80% Upside
Moderna, Inc. stock logo
MRNA
Moderna
1.84
Reduce$35.73-23.78% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.6110.39% Upside

Current Analyst Ratings Breakdown

Latest PFE, AMGN, GILD, and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2026
Amgen Inc. stock logo
AMGN
Amgen
Lower Price TargetBuy$400.00 ➝ $375.00
5/20/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
UpgradeHoldBuy$165.00
5/19/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price TargetOutperform$161.00 ➝ $150.00
5/14/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingUnderperform$26.00
5/14/2026
Amgen Inc. stock logo
AMGN
Amgen
Lower Price TargetOverweight$432.00 ➝ $427.00
5/13/2026
Amgen Inc. stock logo
AMGN
Amgen
Lower Price TargetOutperform$410.00 ➝ $390.00
5/11/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
UpgradeBuy (B-)Buy (B)
5/11/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price Target$170.00 ➝ $167.00
5/8/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price Target$175.00 ➝ $168.00
5/8/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Lower Price Target$148.00 ➝ $146.00
5/8/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Reiterated RatingBuy$155.00 ➝ $157.00
(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$36.75B4.98$33.79 per share10.04$17.03 per share19.92
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$29.44B5.67$10.47 per share12.83$18.87 per share7.12
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B9.57N/AN/A$18.67 per share2.51
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.36$4.40 per share5.89$15.86 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$7.71B$14.3723.6114.403.4120.96%137.41%13.28%8/4/2026 (Estimated)
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$8.51B$7.3418.3114.03N/A30.99%48.19%18.28%8/6/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$8.15N/AN/AN/A-143.55%-26.64%-19.32%7/31/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.799.06N/A11.83%19.44%8.41%8/4/2026 (Estimated)

Latest PFE, AMGN, GILD, and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.91$2.03+$0.12$1.61$6.91 billion$6.96 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
5/1/2026Q1 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$3.02-$3.40-$0.38-$3.40$236.37 million$389.00 million
4/30/2026Q1 2026
Amgen Inc. stock logo
AMGN
Amgen
$4.77$5.15+$0.38$3.34$8.58 billion$8.62 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$10.082.97%+8.27%70.15%14 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.282.44%+3.04%44.69%10 Years
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.64%-13.20%131.30%16 Years

Latest PFE, AMGN, GILD, and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.822.45%6/15/20266/15/20266/29/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
3/4/2026
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.523.09%5/15/20265/15/20266/5/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
5.65
1.26
1.01
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.89
1.97
1.77
Moderna, Inc. stock logo
MRNA
Moderna
0.08
2.41
2.35
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.85%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.30%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
31,500539.68 million535.10 millionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.24 billion1.24 billionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700396.79 million353.93 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Swedbank AB Raises Holdings in Pfizer Inc. $PFE
St. Louis Trust Co Takes Position in Pfizer Inc. $PFE
2 Reasons to Watch PFE and 1 to Stay Cautious
Pfizer Juggles Trial Win, Setback and New Vaccine Bet
Fed Hawks Now Rule. Will Warsh Go Along with Them?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Amgen stock logo

Amgen NASDAQ:AMGN

$339.30 +1.88 (+0.56%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$340.28 +0.98 (+0.29%)
As of 05/22/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$134.36 +3.86 (+2.96%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$134.17 -0.19 (-0.14%)
As of 05/22/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Moderna stock logo

Moderna NASDAQ:MRNA

$46.88 -0.38 (-0.80%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$46.89 +0.01 (+0.02%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Pfizer stock logo

Pfizer NYSE:PFE

$25.92 -0.03 (-0.12%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$25.91 -0.01 (-0.03%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.